Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer ...Middle East

Revolutionary 'off-the-shelf' cancer vaccine designed to prevent the recurrence of oesophageal cancer ITOP1 to enter first-in-human Phase I/IIa clinical development in the VISTA study in H1 2025 Multicentre study to be conducted at four university cancer centres, aiming to raise the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer )

Also on site :

• World’s first true ROBOCOP unveiled as cops deploy ‘Cyborg 1.0’ with facial recognition 360 degree cameras for eyes
• Natalie Portman Makes a Bold Confession About Her Past
• Russia ramps up pressure on all fronts as Ukraine offers to buy US Patriots